Target intelligence / Profile preview

MicroRNA 4648 (MIR4648)

Target
MIR4648
Molecular classification
MicroRNA, non-coding RNA, miRNA (microRNA) family
01

Overview

MicroRNA 4648 (MIR4648) is a human microRNA gene encoding a small, single-stranded non-coding RNA molecule involved in post-transcriptional gene regulation[1]. Mature microRNAs, produced via Drosha and Dicer processing, are loaded into the RNA-induced silencing complex (RISC) and guide this complex to partially complementary mRNAs, resulting in translational repression or destabilization of target transcripts[1][2][4][7]. MicroRNAs, including MIR4648, play fundamental roles in cellular differentiation, development, metabolism, apoptosis, and tumorigenesis[2][5][6]. Alterations in microRNA levels are associated with diverse human diseases; MIR4648 is specifically associated with adamantinous craniopharyngioma according to current gene annotation[1]. MicroRNA mimics are used as research tools to study MIR4648 function in cells[3].\n\nFor future structured data retrieval, scientific databases like GeneCards, miRBase, and MedChemExpress can be referenced for up-to-date functional and genetic information regarding MIR4648[1][3].

Other names
hsa-mir-4648MIR4648microRNA 4648
02

Mechanism of action

For miRNA-targeting agents: gene silencing by mRNA degradation or translational inhibition. These mechanisms are typical, but no drugs for MIR4648 are listed.

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilization and translational inhibitionModulation of cellular development, differentiation, metabolism, proliferation, migration, and apoptosis (functions typical of miRNAs in general, specific functions for MIR4648 may require further research)
04

Disease associations

Possible association with Adamantinous craniopharyngiomaMicroRNAs in general are implicated in cancer, metastasis, cell fate, drug resistance, inflammation, and developmental disorders, but direct disease roles for MIR4648 beyond the above are not established in results
05

Safety considerations

No specific safety concerns or therapeutic challenges are reported for MIR4648.General issues with microRNA-based therapeutics include off-target gene regulation and delivery challenges.
06

Biomarkers

MicroRNAs, including MIR4648, may serve as biomarkers due to their presence in body fluids (circulating miRNAs), but no validated biomarker role for MIR4648 is described.

Beyond the preview

Go deeper on MicroRNA 4648 (MIR4648).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4648 (MIR4648).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call